Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics
Merus stock rocketed — and hammered Bicara — after unveiling promising new results for its experimental head-and-neck cancer treatment.
| Ticker |
MRK
|
| CIK | 0000310158 |
| SIC | 2834 |
| Sector | Manufacturing |
| Industry Category | Pharmaceutical Products |
| Industry Group | Pharmaceutical Preparations |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara TherapeuticsMerus stock rocketed — and hammered Bicara — after unveiling promising new results for its experimental head-and-neck cancer treatment. 3 Dow Jones Stocks on Our WatchlistThe Dow Jones (^DJI) includes some of the most reliable stocks in the market, and while not all are equal, a few continue to shine. These companies are leveraging their strengths to maintain leadership and reward investors. Merck to Participate in the Bernstein 41st Annual Strategic Decisions ConferenceRAHWAY, N.J., May 22, 2025--Merck to Participate in the Bernstein 41st Annual Strategic Decisions Conference Merck & Co., Inc. (MRK): A Bull Case TheoryWe came across a bullish thesis on Merck & Co., Inc. (MRK) on Value Investing Subreddit Page by CompanyCharts. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at $77.23 as of May 19th. MRK’s trailing and forward P/E were 11.23 and 8.64 respectively according to Yahoo […] Merck (NYSE:MRK) Collaborates With Antengene For Promising Cancer Therapy EvaluationIn a recent development, Antengene Corporation Limited announced a global clinical collaboration with Merck (NYSE:MRK) to evaluate ATG-022 in combination with KEYTRUDA®, which could enhance Merck's oncology portfolio. Despite this collaboration and other positive product-related announcements, Merck’s stock price was relatively flat over the past month at a 1% decline. During this time, the broader market posted gains, driven by easing trade concerns and strong corporate earnings. The... |